{"id":"https://openalex.org/W4379285652","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","title":"Outcomes according to treatment received for small node-negative HER2+ breast tumors in the Surveillance, Epidemiology, and End Results (SEER) database, 2010-2019.","display_name":"Outcomes according to treatment received for small node-negative HER2+ breast tumors in the Surveillance, Epidemiology, and End Results (SEER) database, 2010-2019.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379285652","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.517"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.517","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2023.41.16_suppl.517","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2023.41.16_suppl.517","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089866079","display_name":"Adrienne Gropper Waks","orcid":"https://orcid.org/0000-0001-5649-7229","observed_orcids":["https://orcid.org/0000-0001-5649-7229"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrienne Gropper Waks","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081854007","display_name":"Paolo Tarantino","orcid":"https://orcid.org/0000-0001-8686-0228","observed_orcids":["https://orcid.org/0000-0001-8686-0228"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paolo Tarantino","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080530218","display_name":"Rachel A. Freedman","orcid":"https://orcid.org/0000-0003-0460-674X","observed_orcids":["https://orcid.org/0000-0003-0460-674X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel A. Freedman","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062515397","display_name":"Nabihah Tayob","orcid":"https://orcid.org/0000-0001-6088-167X","observed_orcids":["https://orcid.org/0000-0001-6088-167X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nabihah Tayob","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102859764","display_name":"Carlos Teodoro Vallejo","orcid":"https://orcid.org/0000-0003-1255-6738","observed_orcids":["https://orcid.org/0000-0003-1255-6738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Teodoro Vallejo","raw_affiliation_strings":["Unidad Oncologica de Neuquen, Neuquen, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unidad Oncologica de Neuquen, Neuquen, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054533822","display_name":"Julieta Leone","orcid":"https://orcid.org/0000-0003-4990-4679","observed_orcids":["https://orcid.org/0000-0003-4990-4679"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julieta Leone","raw_affiliation_strings":["Cooperative Oncological Group of Sur, Neuqu\u00e9n, Argentina","Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cooperative Oncological Group of Sur, Neuqu\u00e9n, Argentina","institution_ids":[]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069056507","display_name":"Sara M. Tolaney","orcid":"https://orcid.org/0000-0002-5940-8671","observed_orcids":["https://orcid.org/0000-0002-5940-8671"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara M. Tolaney","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055137470","display_name":"Jos\u00e9 Pablo Leone","orcid":"https://orcid.org/0000-0002-8537-652X","observed_orcids":["https://orcid.org/0000-0002-8537-652X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose Pablo Leone","raw_affiliation_strings":["Cooperative Oncological Group of Sur, Neuqu\u00e9n, Argentina","Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cooperative Oncological Group of Sur, Neuqu\u00e9n, Argentina","institution_ids":[]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"517","last_page":"517"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8012999892234802,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8012999892234802,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.18459999561309814,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/node-negative-breast-cancer","display_name":"node-negative breast cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/small-breast-tumors","display_name":"small breast tumors","score":0.7200000286102295},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9750000238418579},{"id":"https://openalex.org/keywords/breast-cancer-specific-survival","display_name":"breast cancer-specific survival","score":0.8980000019073486},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.6320000290870667},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.7139999866485596},{"id":"https://openalex.org/keywords/tumor-size","display_name":"tumor size","score":0.7049999833106995},{"id":"https://openalex.org/keywords/treatment-utilization-trends","display_name":"treatment utilization trends","score":0.4569999873638153},{"id":"https://openalex.org/keywords/seer-database","display_name":"SEER database","score":0.6069999933242798},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5740000009536743},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.4339999854564667},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.5809999704360962},{"id":"https://openalex.org/keywords/adjuvant-radiotherapy","display_name":"adjuvant radiotherapy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/adjuvant-surgery","display_name":"adjuvant surgery","score":0.4569999873638153},{"id":"https://openalex.org/keywords/adjuvant-immunotherapy","display_name":"adjuvant immunotherapy","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9434735774993896},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6426578760147095},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6388929486274719},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6106539368629456},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5664300918579102},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5467629432678223},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5229288339614868},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4908605217933655},{"id":"https://openalex.org/C2779391198","wikidata":"https://www.wikidata.org/wiki/Q7647035","display_name":"Surveillance, Epidemiology, and End Results","level":4,"score":0.47350436449050903},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.46730801463127136},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4325806498527527},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43080365657806396},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.41579392552375793},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.3810817003250122},{"id":"https://openalex.org/C2778527826","wikidata":"https://www.wikidata.org/wiki/Q1787017","display_name":"Cancer registry","level":3,"score":0.3773813545703888},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.11623582243919373},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.517","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2023.41.16_suppl.517","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.517","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.517","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2023.41.16_suppl.517","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7099999785423279,"display_name":"No poverty","id":"https://metadata.un.org/sdg/1"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379285652.pdf","grobid_xml":"https://content.openalex.org/works/W4379285652.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2075464724","https://openalex.org/W2944205208","https://openalex.org/W4237188838","https://openalex.org/W3031309839","https://openalex.org/W4406962996","https://openalex.org/W1991809109","https://openalex.org/W2970780579","https://openalex.org/W2116362697","https://openalex.org/W2068228843","https://openalex.org/W4400273606"],"abstract_inverted_index":{"517":[0],"Background:":[1],"The":[2,92],"magnitude":[3],"of":[4,55,65,75,224,333,337],"systemic":[5,84],"therapy":[6],"(tx)":[7],"benefit":[8,21],"for":[9,34,120,214,270,275],"small,":[10],"node-negative":[11],"HER2+":[12,41,57,153],"breast":[13,42,58,97,154],"tumors":[14],"is":[15,78],"unknown,":[16],"with":[17,37,51,151,341,353,364],"uncertainty":[18],"about":[19],"how":[20],"varies":[22],"across":[23],"stage":[24,38,347,355],"I":[25],"tumor":[26,126,234,265,318,323],"sizes.":[27],"We":[28,147],"analyzed":[29],"treatment":[30,112],"patterns":[31],"and":[32,159,183,201,236,278,350,373],"outcomes":[33,363],"patients":[35],"(pts)":[36],"IA":[39,348,356],"(pT1N0)":[40],"cancer":[43,59],"in":[44,81,88,106,217,344],"the":[45,89,176,218,225,345],"national":[46],"SEER":[47],"database.":[48],"Methods:":[49],"Pts":[50,281,307],"one":[52],"lifetime":[53],"diagnosis":[54,123],"pT1N0":[56,152],"between":[60,111,261],"2010-2019":[61,262],"were":[62,140,249,282,290,308,325],"included.":[63],"Receipt":[64,336],"chemotherapy":[66],"(chemo)":[67],"was":[68,86,96,109,167,172,228,339],"categorized":[69],"as":[70],"yes":[71],"vs":[72,190,197,205,220],"no/unknown;":[73],"receipt":[74],"endocrine":[76],"tx":[77,85],"not":[79,104,244],"available":[80,105],"SEER.":[82],"All":[83],"administered":[87],"adjuvant":[90],"setting.":[91],"primary":[93],"outcome":[94],"variable":[95],"cancer-specific":[98],"survival":[99],"(BCSS;":[100],"recurrence":[101],"events":[102,216,232],"are":[103,239,243],"SEER),":[107],"which":[108],"compared":[110],"groups":[113],"using":[114],"a":[115],"multivariate":[116],"Cox":[117],"model":[118],"adjusted":[119,255],"age":[121,164],"at":[122,165,180],"(dx),":[124],"race,":[125,372],"grade/histology/size,":[127],"hormone":[128],"receptor":[129],"(HR)":[130],"status,":[131,134],"radiation,":[132],"marital":[133,374],"income,":[135,371],"rurality.":[136],"Chemo":[137,257],"use":[138,258],"predictors":[139],"evaluated":[141],"by":[142,233],"multivariable":[143],"logistic":[144],"regression.":[145],"Results:":[146],"identified":[148],"12,861":[149],"pts":[150,352],"cancer;":[155],"9,513":[156],"(74%)":[157],"HR-positive":[158],"3,348":[160],"(26%)":[161],"HR-.":[162],"Median":[163,170],"dx":[166],"59":[168],"yrs.":[169],"follow-up":[171],"46":[173],"months.":[174],"In":[175],"overall":[177,226,346],"cohort,":[178],"BCSS":[179,215,231,343],"3,":[181],"5,":[182],"7":[184],"yrs":[185],"was:":[186],"99.3%":[187],"(with":[188,195,203],"chemo)":[189,196,204],"99.1%":[191],"(without":[192,199,207],"chemo);":[193,200],"98.6%":[194],"97.4%":[198],"97.5%":[202],"96.4%":[206],"chemo),":[208],"respectively.":[209],"Adjusted":[210],"hazard":[211],"ratio":[212],"(HzR)":[213],"chemo":[219,222,287,313,338,377],"no":[221],"group":[223],"cohort":[227,349],"0.63":[229],"(p=0.004;).":[230],"size":[235,266],"HR":[237],"status":[238,375],"shown;":[240],"p":[241,269],"values":[242],"shown":[245],"where":[246],"event":[247],"rates":[248],"too":[250],"low":[251],"to":[252,285,311],"run":[253],"an":[254],"model.":[256],"increased":[259],"significantly":[260],"within":[263],"each":[264],"category":[267],"(all":[268],"trend":[271],"<":[272],"0.04),":[273],"except":[274],"T1a":[276],"HR+/HER2+":[277,354],"T1mi":[279],"HR-/HER2+.":[280],"less":[283],"likely":[284,310],"receive":[286,312],"if":[288,314],"they":[289,315],"older,":[291],"Hispanic":[292],"(vs":[293,297,305,327],"non-Hispanic":[294],"White),":[295],"separated/divorced/widowed":[296],"single),":[298,328],"or":[299,329,365],"had":[300,316,330,361],"lower":[301],"median":[302],"household":[303],"income":[304],">$75K).":[306],"more":[309],"larger":[317],"size,":[319],"HR-":[320],"tumor,":[321],"higher":[322,342],"grade,":[324],"married":[326],"later":[331],"yr":[332],"dx.":[334],"Conclusions:":[335],"associated":[340],"among":[351],"tumors.":[357],"Tumors":[358],"\u2264":[359],"1cm":[360],"excellent":[362],"without":[366],"chemo.":[367],"Sociodemographic":[368],"factors":[369],"including":[370],"impacted":[376],"receipt.":[378],"[Table:":[379],"see":[380],"text]":[381]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-06-05T00:00:00"}